Prisma Biotechnology
PrivateCompany Overview
Prisma Biotechnology operates in Healthcare & Life Sciences and is based in Somerville, Massachusetts. It was founded in 2021.
Prisma Biotechnology is a biotechnology company that develops a protein sequencing platform designed to unveil functional drivers of biology and transform human health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prisma Biotechnology Comparables
Compare Prisma Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Glyphic Biotechnologies | 89% | |
| Erisyon | 88% | |
| Encodia | 83% |
For institutional investors. Book with your work email.
Prisma Biotechnology Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Prisma Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Prisma Biotechnology's valuation, stock price, and market status.
Is Prisma Biotechnology a public or private company?
Prisma Biotechnology is a private company.
What is the current stock price of Prisma Biotechnology?
Prisma Biotechnology is a private company, so its shares have no public market price. Caplight tracks Prisma Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Prisma Biotechnology worth (valuation)?
Valuation information for Prisma Biotechnology is not publicly available.
Can I buy Prisma Biotechnology stock?
Prisma Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Prisma Biotechnology's last funding round?
Funding round information for Prisma Biotechnology is not publicly available.
Who are the main investors in Prisma Biotechnology?
Investor information for Prisma Biotechnology is not publicly disclosed.
Will Prisma Biotechnology IPO soon?
No public IPO plans have been announced for Prisma Biotechnology.
How can I track Prisma Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Prisma Biotechnology's shares on secondary markets.